Harmony Biosciences Holdings, Inc.

HRMYNASDAQHealthcare● Active

$32.30

+$0.10(+0.31%)

Market Cap$1.9B

P/E Ratio—

52W High$40.87

52W Low$25.52

Avg Volume790K

Open$32.36

Beta0.97

Insider Trades Ownership Employees

Harmony Biosciences Holdings, Inc. (HRMY) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · HRMY · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Harmony Biosciences Holdings, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

HRMY insider buying and selling by quarter

HRMY insider selling · HRMY insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

9.2M4.6M0

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · HRMY ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

HRMY executive sell shares · HRMY board member insider trading · HRMY insider trading SEC filing

Showing 43 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 1, 2026	Budur Kumar CHIEF MEDICAL OFFICER	Option	18,750	—	—	32,997	Form 4
May 1, 2026	Budur Kumar CHIEF MEDICAL OFFICER	Other	8,882	$31.83	$283K	24,115	Form 4
Apr 7, 2026	Zaeske Adam H. CHIEF COMMERCIAL OFFICER	Option	7,500	—	—	7,500	Form 4
Apr 7, 2026	Zaeske Adam H. CHIEF COMMERCIAL OFFICER	Other	3,173	$27.62	$88K	4,327	Form 4
Jan 26, 2026	Kapadia Sandip CHIEF FINANCIAL OFFICER	Sale	3,746	$37.15	$139K	24,521	Form 4
Jan 25, 2026	Kapadia Sandip CHIEF FINANCIAL OFFICER	Option	4,725	—	—	4,725	Form 4
Jan 24, 2026	Kapadia Sandip CHIEF FINANCIAL OFFICER	Option	3,813	—	—	3,813	Form 4
Jan 25, 2026	Kapadia Sandip CHIEF FINANCIAL OFFICER	Other	2,553	$36.82	$94K	2,172	Form 4
Jan 24, 2026	Kapadia Sandip CHIEF FINANCIAL OFFICER	Other	2,239	$36.82	$82K	1,574	Form 4
Jan 25, 2026	Serafin Andrew CHIEF STRATEGY OFFICER	Option	2,600	—	—	2,600	Form 4
Jan 24, 2026	Serafin Andrew CHIEF STRATEGY OFFICER	Option	2,500	—	—	2,500	Form 4
Jan 25, 2026	Serafin Andrew CHIEF STRATEGY OFFICER	Other	1,126	$36.82	$41K	1,474	Form 4
Jan 24, 2026	Serafin Andrew CHIEF STRATEGY OFFICER	Other	1,116	$36.82	$41K	1,384	Form 4
Jan 25, 2026	Budur Kumar CHIEF MEDICAL OFFICER	Option	2,662	—	—	2,662	Form 4
Jan 24, 2026	Budur Kumar CHIEF MEDICAL OFFICER	Option	2,188	—	—	2,188	Form 4
Jan 25, 2026	Budur Kumar CHIEF MEDICAL OFFICER	Other	1,372	$36.82	$51K	1,290	Form 4
Jan 24, 2026	Budur Kumar CHIEF MEDICAL OFFICER	Other	1,153	$36.82	$42K	1,035	Form 4
Jan 25, 2026	Dayno Jeffrey M. PRESIDENT, CEO · Director	Option	13,000	—	—	13,000	Form 4
Jan 24, 2026	Dayno Jeffrey M. PRESIDENT, CEO · Director	Option	10,500	—	—	10,500	Form 4
Jan 25, 2026	Dayno Jeffrey M. PRESIDENT, CEO · Director	Other	5,654	$36.82	$208K	7,346	Form 4
Jan 24, 2026	Dayno Jeffrey M. PRESIDENT, CEO · Director	Other	4,785	$36.82	$176K	5,715	Form 4
Jan 15, 2026	Kapadia Sandip CHIEF FINANCIAL OFFICER	Sale	20,961	$35.92	$753K	0	Form 4
Dec 12, 2025	Dayno Jeffrey M. PRESIDENT, CEO · Director	Option	20,000	$8.22	$164K	20,000	Form 4
Dec 12, 2025	Dayno Jeffrey M. PRESIDENT, CEO · Director	Sale	5,933	$40.11	$238K	0	Form 4
Dec 5, 2025	Kapadia Sandip CHIEF FINANCIAL OFFICER	Option	20,000	$29.03	$581K	20,000	Form 4

Budur Kumar

CHIEF MEDICAL OFFICER

Option

Date

May 1

18,750

Price

—

Value

—

View Form 4 on SEC.gov

Budur Kumar

CHIEF MEDICAL OFFICER

Other

Date

May 1

8,882

Price

$31.83

Value

$283K

View Form 4 on SEC.gov

Zaeske Adam H.

CHIEF COMMERCIAL OFFICER

Option

Date

Apr 7

7,500

Price

—

Value

—

View Form 4 on SEC.gov

Zaeske Adam H.

CHIEF COMMERCIAL OFFICER

Other

Date

Apr 7

3,173

Price

$27.62

Value

$88K

View Form 4 on SEC.gov

Kapadia Sandip

CHIEF FINANCIAL OFFICER

Sale

Date

Jan 26

3,746

Price

$37.15

Value

$139K

View Form 4 on SEC.gov

Kapadia Sandip

CHIEF FINANCIAL OFFICER

Option

Date

Jan 25

4,725

Price

—

Value

—

View Form 4 on SEC.gov

Kapadia Sandip

CHIEF FINANCIAL OFFICER

Option

Date

Jan 24

3,813

Price

—

Value

—

View Form 4 on SEC.gov

Kapadia Sandip

CHIEF FINANCIAL OFFICER

Other

Date

Jan 25

2,553

Price

$36.82

Value

$94K

View Form 4 on SEC.gov

Kapadia Sandip

CHIEF FINANCIAL OFFICER

Other

Date

Jan 24

2,239

Price

$36.82

Value

$82K

View Form 4 on SEC.gov

Serafin Andrew

CHIEF STRATEGY OFFICER

Option

Date

Jan 25

2,600

Price

—

Value

—

View Form 4 on SEC.gov

Serafin Andrew

CHIEF STRATEGY OFFICER

Option

Date

Jan 24

2,500

Price

—

Value

—

View Form 4 on SEC.gov

Serafin Andrew

CHIEF STRATEGY OFFICER

Other

Date

Jan 25

1,126

Price

$36.82

Value

$41K

View Form 4 on SEC.gov

Serafin Andrew

CHIEF STRATEGY OFFICER

Other

Date

Jan 24

1,116

Price

$36.82

Value

$41K

View Form 4 on SEC.gov

Budur Kumar

CHIEF MEDICAL OFFICER

Option

Date

Jan 25

2,662

Price

—

Value

—

View Form 4 on SEC.gov

Budur Kumar

CHIEF MEDICAL OFFICER

Option

Date

Jan 24

2,188

Price

—

Value

—

View Form 4 on SEC.gov

Budur Kumar

CHIEF MEDICAL OFFICER

Other

Date

Jan 25

1,372

Price

$36.82

Value

$51K

View Form 4 on SEC.gov

Budur Kumar

CHIEF MEDICAL OFFICER

Other

Date

Jan 24

1,153

Price

$36.82

Value

$42K

View Form 4 on SEC.gov

Dayno Jeffrey M.

PRESIDENT, CEO · Director

Option

Date

Jan 25

13,000

Price

—

Value

—

View Form 4 on SEC.gov

Dayno Jeffrey M.

PRESIDENT, CEO · Director

Option

Date

Jan 24

10,500

Price

—

Value

—

View Form 4 on SEC.gov

Dayno Jeffrey M.

PRESIDENT, CEO · Director

Other

Date

Jan 25

5,654

Price

$36.82

Value

$208K

View Form 4 on SEC.gov

Dayno Jeffrey M.

PRESIDENT, CEO · Director

Other

Date

Jan 24

4,785

Price

$36.82

Value

$176K

View Form 4 on SEC.gov

Kapadia Sandip

CHIEF FINANCIAL OFFICER

Sale

Date

Jan 15

20,961

Price

$35.92

Value

$753K

View Form 4 on SEC.gov

Dayno Jeffrey M.

PRESIDENT, CEO · Director

Option

Date

Dec 12

20,000

Price

$8.22

Value

$164K

View Form 4 on SEC.gov

Dayno Jeffrey M.

PRESIDENT, CEO · Director

Sale

Date

Dec 12

5,933

Price

$40.11

Value

$238K

View Form 4 on SEC.gov

Kapadia Sandip

CHIEF FINANCIAL OFFICER

Option

Date

Dec 5

20,000

Price

$29.03

Value

$581K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About HRMY insider trading

HRMY insider trades

Harmony Biosciences Holdings, Inc. (HRMY) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Kapadia Sandip (CHIEF FINANCIAL OFFICER), Budur Kumar (CHIEF MEDICAL OFFICER), Dayno Jeffrey M. (PRESIDENT, CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. HRMY insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Harmony Biosciences Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

HRMY insider trading · 5 questions

The insiders of Harmony Biosciences Holdings, Inc. (HRMY) include executives and directors such as Kapadia Sandip (CHIEF FINANCIAL OFFICER), Budur Kumar (CHIEF MEDICAL OFFICER), Dayno Jeffrey M. (PRESIDENT, CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

HRMY board member insider tradingwho are HRMY insidersHRMY insider rosterHarmony Biosciences Holdings, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026